Find a Trial
Trial Summary
| Protocol No. | CTO-GOG-3053 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Landrum, Lisa | ||
| Scope | National | ||
| Phase | Phase III | ||
| Age Group | Adult | ||
| Title | A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053). | ||
| Applicable Disease Sites | Other Female Genital | ||
| Participating Institutions | IU Health North Hospital | ||
| Treatment Type | Treatment | ||
| Contact | Phone: (317) 278-5632 Email: iutrials@iu.edu | ||